Skip to content
L 75L 75L 75

Drawing based on the label description. No photo yet.

“Amantadine hydrochloride tablets are available as peach color, round, flat face, beveled-edge mottled tablets, debossed with 'L 75' on one side and plain on other side”

L75 pill

Pill with imprint L75 is orange, round, 7 mm and has been identified as Amantadine 100 mg. It is used for Parkinson's disease and flu. It is supplied by Alembic Pharmaceuticals Limited.

Amantadine 100 mg

Imprint
L75
Strength
100 mg
Used for
Parkinson's disease and flu
Color
Orange
Shape
Round
Size
7 mm
Score
No score line
Form
Tablet
Manufacturer
Alembic Pharmaceuticals Limited
Drug class
Influenza a m2 protein inhibitor
NDC
46708-586, 46708-586-31, 46708-586-71, 67046-1531, 62332-586, 67046-1531-3, 62332-586-31, 62332-586-71, 0615-8605, 0615-8605-39, 82804-267, 82804-267-20

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Amantadine pills and guides

What is Amantadine used for?

Amantadine is used for Parkinson's disease and flu.

Medicine type
Influenza a m2 protein inhibitor
Official uses from the US prescribing label

Amantadine hydrochloride capsules, USP are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules, USP are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions.

Influenza A Prophylaxis

Amantadine hydrochloride capsules, USP are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection. Because amantadine does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. Following vaccination during an influenza A outbreak, amantadine prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response.

Influenza A Treatment

Amantadine hydrochloride capsules, USP are also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza A virus strains especially when administered early in the course of illness. There are no well-controlled clinical studies demonstrating that treatment with amantadine hydrochloride capsules, USP will avoid the development of influenza A virus pneumonitis or other complications in high risk patients.

There is no clinical evidence indicating that amantadine hydrochloride capsules, USP are effective in the prophylaxis or treatment of viral respiratory tract illnesses other than those caused by influenza A virus strains.

The following points should be considered before initiating treatment or prophylaxis with amantadine hydrochloride capsules, USP.

  • Amantadine hydrochloride capsules, USP are not a substitute for early vaccination on an annual basis as recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices.
  • Influenza viruses change over time. Emergence of resistance mutations could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use amantadine hydrochloride capsules, USP.

Parkinson’s Disease/Syndrome

Amantadine hydrochloride capsules, USP are indicated in the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication. It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis. In the treatment of Parkinson's disease, amantadine is less effective than levodopa, (-)-3-(3,4-dihydroxyphenyl)-L-alanine, and its efficacy in comparison with the anticholinergic antiparkinson drugs has not yet been established.

Drug-Induced Extrapyramidal Reactions

Amantadine hydrochloride is indicated in the treatment of drug-induced extrapyramidal reactions. Although anticholinergic-type side effects have been noted with amantadine when used in patients with drug-induced extrapyramidal reactions, there is a lower incidence of these side effects than that observed with the anticholinergic antiparkinson drugs.

From the FDA-approved label on DailyMed (published Jun 18, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows L 75 and the other side is plain.
  • It is orange, round, 7 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Amantadine Hydrochloride

Inactive: Microcrystalline Cellulose, Povidone K30, Povidone K90, Sodium Starch Glycolate Type A Potato, Silicon Dioxide, Magnesium Stearate, Fd&c Yellow No. 6

Also distributed by

Coupler LLC, Alembic Pharmaceuticals Inc., Ncs Healthcare of Ky, LLC Dba Vangard Labs, Proficient Rx LP

Other pills with imprint L75

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Amantadine pills